Guangdong Transtek Medical Electronics Co., Ltd (300562.SZ)
CNY 16.27
(-6.92%)
CNY 16.27
(-6.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 74.14 Million | 84.65 Million | -880.84 Thousand | 77.98 Million | 74.95 Million | 85.15 Million |
| Net Income | 31.19 Million | -38.12 Million | -275.05 Thousand | 67.89 Million | 29.89 Million | 22.03 Million |
| Depreciation & Amortization | 28.9 Million | 30.56 Million | 24.19 Million | 14.7 Million | 14.03 Million | 12.25 Million |
| Deferred income taxes | -1.5 Million | -2.26 Million | -1.88 Million | -399.1 Thousand | -164.03 Thousand | -1.74 Million |
| Stock-based compensation | 3.34 Million | -3.66 Million | 2.89 Million | 6.66 Million | 3.05 Million | 293.52 Thousand |
| Change in working capital | 1.17 Million | 38.77 Million | -45.66 Million | -22.35 Million | 30.65 Million | 34.63 Million |
| Other non-cash items | 12.86 Million | 53.43 Million | 20.86 Million | 17.74 Million | 369.43 Thousand | 16.22 Million |
| Investing Cash Flow | 18.36 Million | 12.53 Million | -183.21 Million | -44.96 Million | -155.03 Million | 36.44 Million |
| Investments in PPE | -12.89 Million | -21.03 Million | -67.77 Million | -99.28 Million | -31.73 Million | -24.85 Million |
| Acquisitions | 770.89 Thousand | 3.39 Million | 67.78 Million | 117.38 | 30.45 Thousand | -3.4 Million |
| Investment purchases | -1.11 Billion | -326.37 Million | -449.2 Million | -128.51 Million | -469.5 Million | -519.99 Million |
| Sales/Maturities of investments | 1.15 Billion | 363.66 Million | 333.75 Million | 220.82 Million | 348.11 Million | 589.9 Million |
| Other Investing Activities | -4.75 Million | -7.1 Million | -67.77 Million | -37.98 Million | -1.93 Million | -5.2 Million |
| Financing Cash Flow | -11.4 Million | 107.37 Million | 315.49 Million | 12.63 Million | 7.02 Million | -6.54 Million |
| Debt repayment | -172 Million | -17.21 Million | -137.06 Million | -62.53 Million | -65.12 Million | -49.11 Million |
| Dividends payments | -2.14 Million | -2.14 Million | -42.93 Million | -4.18 Million | -3.22 Million | -5.5 Million |
| Common Stock Repurchased | - | -232.06 Thousand | -1.37 Million | -476.14 Thousand | - | - |
| Common Stock Issuance | - | 232.06 Thousand | 1.37 Million | 476.14 Thousand | - | - |
| Other Financing Activities | 166.24 Million | 128.13 Million | 497.23 Million | 80.01 Million | 76.51 Million | 48.07 Million |
| Accounts receivables | -16.17 Million | 222.62 Million | -71.03 Million | -115.91 Million | -25.62 Million | -33.9 Million |
| Accounts payables | -10.08 Million | -247.68 Million | 12.03 Million | 225.96 Million | 61.28 Million | 78.91 Million |
| Inventory | 28.94 Million | 66.09 Million | 15.21 Million | -132 Million | -4.84 Million | -8.62 Million |
| Other working capital | -1.5 Million | -2.26 Million | -1.88 Million | -399.1 Thousand | -164.03 Thousand | 43.25 Million |
| Cash at beginning of period | 544.93 Million | 328.7 Million | 197.56 Million | 162.27 Million | 233.42 Million | 119.05 Million |
| Cash at end of period | 629.76 Million | 544.93 Million | 328.7 Million | 197.56 Million | 162.27 Million | 233.42 Million |
| Capital Expenditure | -12.89 Million | -21.03 Million | -67.77 Million | -99.28 Million | -31.73 Million | -24.85 Million |
| Effect of forex changes on cash | 3.72 Million | 11.66 Million | -255.26 Thousand | -10.36 Million | 1.89 Million | -689.11 Thousand |
| Net cash flow / Change in cash | 84.83 Million | 216.22 Million | 131.13 Million | 35.28 Million | -71.15 Million | 114.36 Million |
| Free Cash Flow | 61.24 Million | 63.61 Million | -68.65 Million | -21.29 Million | 43.22 Million | 60.3 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15.67 Million | 21.18 Million | 13.66 Million | 31.19 Million | 19.18 Million | 6.54 Million |
| Depreciation & Amortization | - | 7.56 Million | 7.56 Million | 28.9 Million | 7.87 Million | 7.87 Million |
| Deferred income taxes | - | - | - | -1.5 Million | -16.1 Million | 1.11 Million |
| Stock-based compensation | - | 5.87 Million | - | 3.34 Million | 3.34 Million | 1.34 Million |
| Change in working capital | - | -22.69 Million | - | 1.17 Million | 12.76 Million | -2.46 Million |
| Other non-cash items | 24.99 Million | 36.43 Million | -29.99 Million | 12.86 Million | -504.61 Thousand | 50.39 Million |
| Investing Cash Flow | -364.72 Million | 298.46 Million | -306.49 Million | 18.36 Million | 307.02 Million | -125.11 Million |
| Investments in PPE | -12.07 Million | -4.99 Million | -6.4 Million | -12.89 Million | 256.64 Thousand | -4.62 Million |
| Acquisitions | 343.36 Thousand | 460 Thousand | - | 770.89 Thousand | 128.6 Thousand | 347.14 |
| Investment purchases | 878 Million | -878 Million | - | -1.11 Billion | -1.09 Billion | -11 Million |
| Sales/Maturities of investments | -878 Million | 878 Million | 2.9 Million | 1.15 Billion | 1.14 Billion | 511.45 Thousand |
| Other Investing Activities | -353 Million | 303 Million | -303 Million | -4.75 Million | 250.24 Million | -109.99 Million |
| Financing Cash Flow | -44.17 Million | 4.25 Million | -8.99 Million | -11.4 Million | -68.56 Million | 61.5 Million |
| Debt repayment | -15.28 Million | -39.9 Million | -2 Million | -172 Million | -61.55 Million | -110.15 Million |
| Dividends payments | - | -32.41 Million | -238.38 Thousand | -2.14 Million | -2.14 Million | -1.27 Million |
| Common Stock Repurchased | 20.5 Million | -20.5 Million | - | - | - | - |
| Common Stock Issuance | -6.51 Million | 6.51 Million | - | - | - | - |
| Other Financing Activities | -42.87 Million | 10.87 Million | -10.75 Million | 166.24 Million | -6.69 Million | 172.93 Million |
| Accounts receivables | - | -11.78 Million | - | -16.17 Million | -16.17 Million | 28.96 Million |
| Accounts payables | - | - | - | -10.08 Million | - | - |
| Inventory | - | -10.91 Million | - | 28.94 Million | 28.94 Million | -31.42 Million |
| Other working capital | - | - | - | -1.5 Million | - | - |
| Cash at beginning of period | 695.55 Million | 339.14 Million | 629.76 Million | 544.93 Million | 365.53 Million | 365.55 Million |
| Cash at end of period | 331.65 Million | 695.55 Million | 299.24 Million | 629.76 Million | 629.76 Million | 365.53 Million |
| Capital Expenditure | -12.07 Million | -4.99 Million | -6.4 Million | -12.89 Million | 256.64 Thousand | -4.62 Million |
| Effect of forex changes on cash | - | 5.63 Million | 1.3 Million | 3.72 Million | -798.78 Thousand | -714.1 Thousand |
| Net cash flow / Change in cash | -363.9 Million | 356.41 Million | -330.51 Million | 84.83 Million | 264.22 Million | -16.29 Thousand |
| Free Cash Flow | 28.59 Million | 45.05 Million | -22.72 Million | 61.24 Million | 26.81 Million | 60.19 Million |
8395
BCNAF
TTGT
NXSCF
AYMSYNTEX
VAPIENTER